Key Financial Results (₹ in Lakhs)
Quarter Ended June 30, 2026 (Unaudited):
- Net sales/income from operations: ₹817.69
- Total revenue from operations: ₹817.69
- Total expenses: ₹805.19
- Profit from operations before tax: ₹12.51
- Tax expense: ₹3.13 (Current Tax)
- Net profit for the quarter: ₹9.38
- Earnings per share (Basic & Diluted): ₹0.034
- Paid-up equity share capital: ₹2,797.20 (Face value ₹10 per share)
Comparative Performance:
- Net profit improved from loss of ₹10.31 lakh in Q1 FY26 to profit of ₹9.38 lakh in Q1 FY27
- Revenue increased significantly from ₹26.52 lakh in Q1 FY26 to ₹817.69 lakh in Q1 FY27
Segment-wise Performance (₹ in Lakhs)
Software Development Segment:
- Revenue: ₹25.30
- Segment result: Loss of ₹4.56 before tax and interest
Processing & Trading in Agri Products Segment:
- Revenue: ₹792.39
- Segment result: Profit of ₹17.06 before tax and interest
Additional Information
- The Board meeting commenced at 3:00 PM IST and concluded at 4:00 PM IST on August 12, 2026
- The financial results were reviewed by the Audit Committee and include a Limited Review Report from statutory auditors SNMR & Associates
- The company operates in two segments: (i) Software Development and (ii) Processing & Trading in Agri Products
Material Developments
1. Labour Code Impact: The company has assessed financial implications of new labour codes notified by Ministry of Labour and Employment on November 21, 2025, which resulted in increased employee benefit expenses. However, considering materiality, this was not disclosed as an exceptional item.
2. Amalgamation Scheme: The Board approved a Scheme of Amalgamation of Radical Bio-Organics Limited with the company on April 11, 2026, with April 1, 2026 as the Appointed Date. The scheme is subject to approvals from Stock Exchanges, SEBI, shareholders, creditors, NCLT and other regulatory authorities.